Marcin Kurowski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcin Kurowski has a total of 372 co-authors. Here are the top co-authors by number of shared publications:
- Marek Leszek Kowalski
Department of Immunology and Allergy, Medical University of Lodz, Lodz, Poland
17 shared publications - Hubert Krysztofiak
National Centre for Sports Medicine, Warsaw, Poland
6 shared publications - Mariana Couto
Immunoallergology Hospital CUF Trindade Porto Portugal
6 shared publications - Anna Lewandowska-Polak
Department of Rheumatology, Medical University of Lodz, Lodz, Poland
5 shared publications - Luís Delgado
Basic and Clinical Immunology, Department of Pathology, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
5 shared publications - Maciej Chałubiński
Department of Immunology and Allergy, Medical University of Lodz, 92-213 Lodz, Poland
5 shared publications
Latest Publications
- Open Access
- 1 November 2026
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 19, 1-11
Complete Blood Count-Derived Inflammatory Indices and Reaction Severity in Adults with IgE-Mediated Food Allergy: A Retrospective Case-Control Study
Purpose: In recent years, an increasing number of studies have focused on markers of systemic inflammation calculated from a complete blood count (CBC) as potential predictors of the onset or severity of various diseases, including inflammatory conditions. The aim of this study was to assess these indices in relation to the presence and severity IgE-mediated food allergic reaction in adults. Patients and Methods: A retrospective analysis of 67 adult patients with confirmed IgE-mediated food allergy and 33 healthy controls without allergic diseases was conducted. The severity of allergic reactions was analyzed, along with laboratory test results obtained at least 4 weeks after the reaction had occurred after the last systemic food-induced reaction. Results: ELR was significantly higher in patients than in controls (median, 0.108 vs 0.071; p=0.001). No between-group differences were observed for MLR, NLR, BLR, SII, SIRI, or AISI. None of the indices correlated significantly with WAO grading scale reaction severity or total IgE. In adjusted logistic regression models, none of the indices was independently associated with severe food-allergic reactions. BLR demonstrated the strongest, although nonsignificant, association. Conclusion: ELR differed between patients with food allergy and healthy controls, but neither ELR nor the other systemic inflammation indices correlated with reaction severity. Interpretation of these findings should account for the potential influence of concomitant allergic diseases, which were prevalent in the study population. The utility of these indices as biomarkers of allergic reactions, including anaphylaxis, remains to be established and warrants further investigation, supported by the low cost and widespread availability of complete blood count testing.
- 1 November 2026
- Published by Taylor & Francis in Journal of Asthma and Allergy
- Vol. ume 19, 1-11
Open AccessComplete Blood Count-Derived Inflammatory Indices and Reaction Severity in Adults with IgE-Mediated Food Allergy: A Retrospective Case-Control Study
Purpose: In recent years, an increasing number of studies have focused on markers of systemic inflammation calculated from a complete blood count (CBC) as potential predictors of the onset or severity of various diseases, including inflammatory conditions. The aim of this study was to assess these indices in relation to the presence and severity IgE-mediated food allergic reaction in adults. Patients and Methods: A retrospective analysis of 67 adult patients with confirmed IgE-mediated food allergy and 33 healthy controls without allergic diseases was conducted. The severity of allergic reactions was analyzed, along with laboratory test results obtained at least 4 weeks after the reaction had occurred after the last systemic food-induced reaction. Results: ELR was significantly higher in patients than in controls (median, 0.108 vs 0.071; p=0.001). No between-group differences were observed for MLR, NLR, BLR, SII, SIRI, or AISI. None of the indices correlated significantly with WAO grading scale reaction severity or total IgE. In adjusted logistic regression models, none of the indices was independently associated with severe food-allergic reactions. BLR demonstrated the strongest, although nonsignificant, association. Conclusion: ELR differed between patients with food allergy and healthy controls, but neither ELR nor the other systemic inflammation indices correlated with reaction severity. Interpretation of these findings should account for the potential influence of concomitant allergic diseases, which were prevalent in the study population. The utility of these indices as biomarkers of allergic reactions, including anaphylaxis, remains to be established and warrants further investigation, supported by the low cost and widespread availability of complete blood count testing.
- Open Access
- 25 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8570
Metal Hypersensitivity in Total Joint Arthroplasty: Molecular Immunopathogenesis, Diagnostic Controversies, and Prospects for Precision Medicine
Implant-related metal hypersensitivity (MH) after total joint arthroplasty (TJA) is an uncommon and diagnostically challenging complication in which antigen-specific T-cell responses may coexist with nonspecific inflammatory reactions to wear and corrosion products. This narrative review critically summarizes current evidence on the molecular immunopathogenesis, clinical presentation, diagnosis, and management of suspected MH, with particular emphasis on HLA-associated susceptibility and the 2023 European Academy of Allergy and Clinical Immunology (EAACI) mechanistic nomenclature. A structured search of PubMed, Scopus, and Web of Science was used to identify relevant clinical, immunological, and consensus literature. Metal sensitization is substantially more common than clinically relevant implant-associated hypersensitivity, and positive patch or lymphocyte transformation tests do not by themselves establish causality. Current evidence supports selective, clinically contextualized testing after exclusion of infection and mechanical causes; routine preoperative screening in patients without a suggestive history is not recommended. HLA class II associations and metal–peptide–MHC/T-cell receptor interactions provide a plausible molecular basis for interindividual susceptibility, but available genetic data remain insufficient for clinical risk stratification or implant selection. Future studies should integrate standardized phenotyping, quantitative metal exposure, histopathology, and molecular immune profiling before implementing precision arthroplasty.
- 25 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8570
Open AccessMetal Hypersensitivity in Total Joint Arthroplasty: Molecular Immunopathogenesis, Diagnostic Controversies, and Prospects for Precision Medicine
Implant-related metal hypersensitivity (MH) after total joint arthroplasty (TJA) is an uncommon and diagnostically challenging complication in which antigen-specific T-cell responses may coexist with nonspecific inflammatory reactions to wear and corrosion products. This narrative review critically summarizes current evidence on the molecular immunopathogenesis, clinical presentation, diagnosis, and management of suspected MH, with particular emphasis on HLA-associated susceptibility and the 2023 European Academy of Allergy and Clinical Immunology (EAACI) mechanistic nomenclature. A structured search of PubMed, Scopus, and Web of Science was used to identify relevant clinical, immunological, and consensus literature. Metal sensitization is substantially more common than clinically relevant implant-associated hypersensitivity, and positive patch or lymphocyte transformation tests do not by themselves establish causality. Current evidence supports selective, clinically contextualized testing after exclusion of infection and mechanical causes; routine preoperative screening in patients without a suggestive history is not recommended. HLA class II associations and metal–peptide–MHC/T-cell receptor interactions provide a plausible molecular basis for interindividual susceptibility, but available genetic data remain insufficient for clinical risk stratification or implant selection. Future studies should integrate standardized phenotyping, quantitative metal exposure, histopathology, and molecular immune profiling before implementing precision arthroplasty.
- Open Access
- 12 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (16) , 2544
Unmasking Incontinentia Pigmenti: A Multimodal Clinico-Dermoscopic and Pathologic Correlation
Incontinentia pigmenti (IP) is a rare, X-linked dominant genodermatosis caused by mutations in the IKBKG gene and characterized by sequential cutaneous stages following the lines of Blaschko. The highly inflammatory initial vesiculobullous stage frequently mimics severe neonatal infections, such as herpes simplex or bullous impetigo, leading to potentially dangerous diagnostic delays and unnecessary antimicrobial therapies. The objective of this report is to highlight the utility of multimodal medical imaging and clinico-pathologic correlation in the rapid diagnosis of early-stage IP. We present the case of a full-term female neonate presenting on the third day of life with a rapidly disseminating blistering eruption, initially treated as a widespread infectious process. A multimodal diagnostic approach was applied, incorporating bedside clinico-dermoscopic evaluation of the infant and her mother (who reported a history of early miscarriages), followed by neonatal skin biopsy, immunohistochemistry (S-100, MART-1), and subsequent genetic testing. Dermoscopy of the neonate’s transitional lesions revealed early dermal melanophage accumulation, while maternal evaluation exposed pathognomonic residual Blaschko-linear dyspigmentation featuring a distinct “pepper-like” dermoscopic pattern. Histopathology demonstrated classic eosinophilic spongiosis, intraepidermal vesicles, and early pigment incontinence. Genetic testing confirmed recurrent IKBKG exon 4–10 deletion. Crucially, this rapid diagnosis facilitated immediate targeted ophthalmologic screening, detecting asymptomatic stage 2B retinal vasculopathy. Integrating noninvasive dermoscopy with precise histopathologic correlation offers a rapid, highly effective framework to distinguish early IP from neonatal blistering infections. Timely multimodal imaging is crucial for triggering immediate multidisciplinary screening, effectively preventing severe, irreversible vision-threatening complications.
- 12 August 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (16) , 2544
Open AccessUnmasking Incontinentia Pigmenti: A Multimodal Clinico-Dermoscopic and Pathologic Correlation
Incontinentia pigmenti (IP) is a rare, X-linked dominant genodermatosis caused by mutations in the IKBKG gene and characterized by sequential cutaneous stages following the lines of Blaschko. The highly inflammatory initial vesiculobullous stage frequently mimics severe neonatal infections, such as herpes simplex or bullous impetigo, leading to potentially dangerous diagnostic delays and unnecessary antimicrobial therapies. The objective of this report is to highlight the utility of multimodal medical imaging and clinico-pathologic correlation in the rapid diagnosis of early-stage IP. We present the case of a full-term female neonate presenting on the third day of life with a rapidly disseminating blistering eruption, initially treated as a widespread infectious process. A multimodal diagnostic approach was applied, incorporating bedside clinico-dermoscopic evaluation of the infant and her mother (who reported a history of early miscarriages), followed by neonatal skin biopsy, immunohistochemistry (S-100, MART-1), and subsequent genetic testing. Dermoscopy of the neonate’s transitional lesions revealed early dermal melanophage accumulation, while maternal evaluation exposed pathognomonic residual Blaschko-linear dyspigmentation featuring a distinct “pepper-like” dermoscopic pattern. Histopathology demonstrated classic eosinophilic spongiosis, intraepidermal vesicles, and early pigment incontinence. Genetic testing confirmed recurrent IKBKG exon 4–10 deletion. Crucially, this rapid diagnosis facilitated immediate targeted ophthalmologic screening, detecting asymptomatic stage 2B retinal vasculopathy. Integrating noninvasive dermoscopy with precise histopathologic correlation offers a rapid, highly effective framework to distinguish early IP from neonatal blistering infections. Timely multimodal imaging is crucial for triggering immediate multidisciplinary screening, effectively preventing severe, irreversible vision-threatening complications.
- Open Access
- 3 August 2026
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 94 (4) , 56
Timothy Grass Pollen-Specific Immunoglobulin E in Nasal Secretions During Natural Allergen Exposure and After a Nasal Provocation Test in Patients with Suspected Local Allergic Rhinitis
Introduction: Allergic rhinitis (AR) imposes a substantial burden on individuals worldwide. Local allergic rhinitis (LAR) patients exhibit symptoms similar to those of AR without a positive skin prick test (SPT) or the presence of sIgE specific to one or more allergens. Our study evaluated specific and total grass pollen IgE in the nasal secretions of patients with suspected LAR, examining the effects of natural pollen exposure and nasal provocation testing (NPT). Methods: Twenty-nine subjects (18 with suspected LAR and 11 with AR) were included in this study. The total nasal symptom score (TNSS) and visual analog scale (VAS) were used for subjective assessment. NPT was performed using grass pollen allergen. Nasal lavage was used to obtain nasal secretions, and the levels of sIgE and total IgE were measured. Results: During the exposure vs. the off-exposure period, the TNSS and VAS were significantly higher in LAR (p < 0.0001 and p = 0.0061, respectively). sIgE and total IgE were significantly higher in the AR group than in the LAR group during the exposure period (p = 0.0008 and p = 0.0491, respectively). LAR diagnosis was confirmed in seven subjects. TNSS and VAS scores were higher after a positive NPT. The median level of sIgE was lower in the negative and positive NPT. A higher median total IgE level was observed post-provocation in both groups. A significantly higher median relative sIgE level was noted after positive and negative provocation (p = 0.0156 and p = 0.0143, respectively). Conclusions: The assessment of local sIgE levels in nasal secretions can be used as a method for the diagnostic workup of patients with suspected LAR. Achieving a well-defined and standardized protocol for the assessment of sIgE concentrations in nasal secretions of LAR is a goal of future larger studies.
- 3 August 2026
- Published by MDPI AG in Advances in Respiratory Medicine
- Vol. 94 (4) , 56
Open AccessTimothy Grass Pollen-Specific Immunoglobulin E in Nasal Secretions During Natural Allergen Exposure and After a Nasal Provocation Test in Patients with Suspected Local Allergic Rhinitis
Introduction: Allergic rhinitis (AR) imposes a substantial burden on individuals worldwide. Local allergic rhinitis (LAR) patients exhibit symptoms similar to those of AR without a positive skin prick test (SPT) or the presence of sIgE specific to one or more allergens. Our study evaluated specific and total grass pollen IgE in the nasal secretions of patients with suspected LAR, examining the effects of natural pollen exposure and nasal provocation testing (NPT). Methods: Twenty-nine subjects (18 with suspected LAR and 11 with AR) were included in this study. The total nasal symptom score (TNSS) and visual analog scale (VAS) were used for subjective assessment. NPT was performed using grass pollen allergen. Nasal lavage was used to obtain nasal secretions, and the levels of sIgE and total IgE were measured. Results: During the exposure vs. the off-exposure period, the TNSS and VAS were significantly higher in LAR (p < 0.0001 and p = 0.0061, respectively). sIgE and total IgE were significantly higher in the AR group than in the LAR group during the exposure period (p = 0.0008 and p = 0.0491, respectively). LAR diagnosis was confirmed in seven subjects. TNSS and VAS scores were higher after a positive NPT. The median level of sIgE was lower in the negative and positive NPT. A higher median total IgE level was observed post-provocation in both groups. A significantly higher median relative sIgE level was noted after positive and negative provocation (p = 0.0156 and p = 0.0143, respectively). Conclusions: The assessment of local sIgE levels in nasal secretions can be used as a method for the diagnostic workup of patients with suspected LAR. Achieving a well-defined and standardized protocol for the assessment of sIgE concentrations in nasal secretions of LAR is a goal of future larger studies.
- Open Access
- 14 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3800
Acquired Angioedema—A Challenge in Medical Practice: A Narrative Review
Angioedema (AE) is a frequent symptom reported by dermatologists and allergists, as well as by general practitioners and physicians in other specialties. Hereditary angioedema (HAE) is an ultra-rare condition, whereas the majority of AE episodes in daily medical practice are secondary to an underlying condition or drug intake. This review discusses the most common causes of acquired angioedema, presents selected aspects of its pathogenesis in the context of available diagnostic tests, and provides an account of reports on possible management options. Acquired angioedema (AAE) poses an actual challenge both in terms of its diagnosis and management. Its variable etiology warrants a diagnostic approach aimed at the exclusion of underlying cancers, lympho- and myeloproliferative diseases, monoclonal gammopathies, as well as autoimmune and infectious conditions. Apart from its variable etiology, the management of AAE is further complicated by the lack of approved and standardized prophylaxis and treatment schemes. Therefore, an appropriate diagnostic approach is required for the efficient prevention of AAE symptoms and the detection of possible underlying pathologies.
- 14 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3800
Open AccessAcquired Angioedema—A Challenge in Medical Practice: A Narrative Review
Angioedema (AE) is a frequent symptom reported by dermatologists and allergists, as well as by general practitioners and physicians in other specialties. Hereditary angioedema (HAE) is an ultra-rare condition, whereas the majority of AE episodes in daily medical practice are secondary to an underlying condition or drug intake. This review discusses the most common causes of acquired angioedema, presents selected aspects of its pathogenesis in the context of available diagnostic tests, and provides an account of reports on possible management options. Acquired angioedema (AAE) poses an actual challenge both in terms of its diagnosis and management. Its variable etiology warrants a diagnostic approach aimed at the exclusion of underlying cancers, lympho- and myeloproliferative diseases, monoclonal gammopathies, as well as autoimmune and infectious conditions. Apart from its variable etiology, the management of AAE is further complicated by the lack of approved and standardized prophylaxis and treatment schemes. Therefore, an appropriate diagnostic approach is required for the efficient prevention of AAE symptoms and the detection of possible underlying pathologies.
- Open Access
- 11 May 2026
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 26 (1) , 34
MicroRNAs as current diagnostic biomarkers and potential therapeutic targets in allergic and non-allergic rhinitis – A functional characterization
Purpose of review: Allergic rhinitis affects up to one-quarter of the population in industrialized countries. This chronic inflammatory disease of the nasal mucosa is triggered by allergen exposure and mediated by immunoglobulin E, leading to immune dysregulation. Diagnosis typically relies upon skin prick tests, serum-specific immunoglobulin E levels and nasal allergen provocations. Differentiation from non-allergic rhinitis remains a diagnostic challenge. Recent research has identified novel microRNAs, small non-coding RNA regulating post-transcriptional gene expression, as key regulators of immunological pathways with great potential as disease-specific targets in diagnostics and therapy. The purpose of this review is to explore novel therapeutic and diagnostic possibilities regarding novel miRNAs. Recent findings: This functional review evaluated current evidence specific to miRNA expression in allergic and non-allergic rhinitis. Seven microRNAs (miR-29a, miR-135a, miR-143, miR-146a, miR-150-5p, miR-223, miR-451) are discussed as potential diagnostic markers and therapeutic agents in the future. Interventional studies, including human and animal studies, are reviewed. The available evidence suggested that selected microRNAs may show specificity and sensitivity as biomarkers for allergic and non-allergic rhinitis in future human trials. Therapeutic options involving miRNAs have shown great promise but still lack validation in clinical studies. In this review, we have identified several challenges in microRNA-based diagnostic approaches and suggested strategies to facilitate future development. Summary: MiRNA research in AR has revealed their role as both diagnostic biomarkers and therapeutic agents in several different mechanisms that are currently under investigation. Dysregulation of miRNA expression has been documented in asthma and allergic rhinitis, but data regarding non-allergic rhinitis remain limited.
- 11 May 2026
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 26 (1) , 34
Open AccessMicroRNAs as current diagnostic biomarkers and potential therapeutic targets in allergic and non-allergic rhinitis – A functional characterization
Purpose of review: Allergic rhinitis affects up to one-quarter of the population in industrialized countries. This chronic inflammatory disease of the nasal mucosa is triggered by allergen exposure and mediated by immunoglobulin E, leading to immune dysregulation. Diagnosis typically relies upon skin prick tests, serum-specific immunoglobulin E levels and nasal allergen provocations. Differentiation from non-allergic rhinitis remains a diagnostic challenge. Recent research has identified novel microRNAs, small non-coding RNA regulating post-transcriptional gene expression, as key regulators of immunological pathways with great potential as disease-specific targets in diagnostics and therapy. The purpose of this review is to explore novel therapeutic and diagnostic possibilities regarding novel miRNAs. Recent findings: This functional review evaluated current evidence specific to miRNA expression in allergic and non-allergic rhinitis. Seven microRNAs (miR-29a, miR-135a, miR-143, miR-146a, miR-150-5p, miR-223, miR-451) are discussed as potential diagnostic markers and therapeutic agents in the future. Interventional studies, including human and animal studies, are reviewed. The available evidence suggested that selected microRNAs may show specificity and sensitivity as biomarkers for allergic and non-allergic rhinitis in future human trials. Therapeutic options involving miRNAs have shown great promise but still lack validation in clinical studies. In this review, we have identified several challenges in microRNA-based diagnostic approaches and suggested strategies to facilitate future development. Summary: MiRNA research in AR has revealed their role as both diagnostic biomarkers and therapeutic agents in several different mechanisms that are currently under investigation. Dysregulation of miRNA expression has been documented in asthma and allergic rhinitis, but data regarding non-allergic rhinitis remain limited.
- Open Access
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1846379
Editorial: Allergen cross-reactivity - a challenge in daily practice
Reina et al. [8] in their original research explored cross-sensitization and crossreactivity between the allergens of house dust mites (HDM) and cockroaches in the tropical environment. Their results identify house dust mite allergens as primary sensitizers in inhabitants of a tropical environment of the city of Cartagena, Colombia. In addition, these authors have explored cross-sensitizations between HDM allergenic proteins and those of cockroaches, shrimp, and Anisakis simplex, concluding that cockroach sensitization should be considered as important hallmark of potential cross-reactivity with allergens coming from crustaceans, and, therefore, warrant more thorough approach during clinical assessment.In the second original paper in this Research Topic, Maskey et al. [9] approach, using the mouse model, an important clinical problem of cross-reactivity between peanut and tree nut allergens. In an attempt to study this potential cross-sensitization, an intraperitoneal sensitization (priming) with a mix of peanut, tree nuts and cashew allergens was performed, and subsequently, specific IgE levels against priming and potentially cross-reactive allergens were measured. Broad cross-reactivity was ascertained, as assessed through specific IgE levels, additionally confirmed by experimental anaphylaxis. Development of this model can be considered a valuable contribution to the advancement of the research on nut cross-reactivity. This Research Topic also contains 2 review papers, which present topics valuable from both basic and clinical points of view. Berghea et al. [10], in their narrative review, describe the wide spectrum of allergic sensitization to spices and herbs, with special focus on the pediatric population. Both IgE-dependent and non-IgE-dependent mechanisms have been highlighted, and the problem of cross-reactivity with pollen allergens was indicated. In the second review contained in this Topic, O'Malley et al. [11] describe calcium-binding proteins (CBPs), an important yet often neglected family of allergenic proteins that, on a standard basis, is not considered a potential cause of cross-reactive reactions. Calcium-binding proteins, due to their heterogeneity, crossreactivity, and presence in multiple allergenic sources, are difficult to avoid. The fact that CBPs can sensitize both through inhalation and ingestion makes them even more worth consideration in the course of a diagnostic approach in an allergy practice.Finally, Schreiber and Guillet [12] presented a description of a rare case of severe IgEmediated hypersensitivity to carboxymethylcellulose (CMC) following an intraarticular knee injection with triamcinolone acetonide. A thorough diagnostic approach allowed them to diagnose a patient with IgE-mediated, and clinically relevant, hypersensitivity to CMC, yet with confirmed lack of sensitization to potentially cross-reactive cellulose derivatives. Reports describing rare cases of IgEmediated generalized reactions to less obvious agents, such as excipients exemplified by CMC, largely contribute to expanding our knowledge and increase our vigilance and critical thinking. Such an approach is irreplaceable when aiming at highest levels of diagnostic insightfulness and thoroughness.
- 21 April 2026
- Published by Frontiers Media SA in Frontiers in Allergy
- Vol. 7, 1846379
Open AccessEditorial: Allergen cross-reactivity - a challenge in daily practice
Reina et al. [8] in their original research explored cross-sensitization and crossreactivity between the allergens of house dust mites (HDM) and cockroaches in the tropical environment. Their results identify house dust mite allergens as primary sensitizers in inhabitants of a tropical environment of the city of Cartagena, Colombia. In addition, these authors have explored cross-sensitizations between HDM allergenic proteins and those of cockroaches, shrimp, and Anisakis simplex, concluding that cockroach sensitization should be considered as important hallmark of potential cross-reactivity with allergens coming from crustaceans, and, therefore, warrant more thorough approach during clinical assessment.In the second original paper in this Research Topic, Maskey et al. [9] approach, using the mouse model, an important clinical problem of cross-reactivity between peanut and tree nut allergens. In an attempt to study this potential cross-sensitization, an intraperitoneal sensitization (priming) with a mix of peanut, tree nuts and cashew allergens was performed, and subsequently, specific IgE levels against priming and potentially cross-reactive allergens were measured. Broad cross-reactivity was ascertained, as assessed through specific IgE levels, additionally confirmed by experimental anaphylaxis. Development of this model can be considered a valuable contribution to the advancement of the research on nut cross-reactivity. This Research Topic also contains 2 review papers, which present topics valuable from both basic and clinical points of view. Berghea et al. [10], in their narrative review, describe the wide spectrum of allergic sensitization to spices and herbs, with special focus on the pediatric population. Both IgE-dependent and non-IgE-dependent mechanisms have been highlighted, and the problem of cross-reactivity with pollen allergens was indicated. In the second review contained in this Topic, O'Malley et al. [11] describe calcium-binding proteins (CBPs), an important yet often neglected family of allergenic proteins that, on a standard basis, is not considered a potential cause of cross-reactive reactions. Calcium-binding proteins, due to their heterogeneity, crossreactivity, and presence in multiple allergenic sources, are difficult to avoid. The fact that CBPs can sensitize both through inhalation and ingestion makes them even more worth consideration in the course of a diagnostic approach in an allergy practice.Finally, Schreiber and Guillet [12] presented a description of a rare case of severe IgEmediated hypersensitivity to carboxymethylcellulose (CMC) following an intraarticular knee injection with triamcinolone acetonide. A thorough diagnostic approach allowed them to diagnose a patient with IgE-mediated, and clinically relevant, hypersensitivity to CMC, yet with confirmed lack of sensitization to potentially cross-reactive cellulose derivatives. Reports describing rare cases of IgEmediated generalized reactions to less obvious agents, such as excipients exemplified by CMC, largely contribute to expanding our knowledge and increase our vigilance and critical thinking. Such an approach is irreplaceable when aiming at highest levels of diagnostic insightfulness and thoroughness.
- Open Access
Chronic Respiratory Diseases: The Stories You Don’t Want to Miss
Chronic respiratory disease is rarely boring
Open AccessChronic Respiratory Diseases: The Stories You Don’t Want to Miss
Chronic respiratory disease is rarely boring
- Open Access
Inflammation Indices as Predictive Markers of Muscle-Invasive Bladder Cancer
Introduction: Prompt diagnosis and differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) are essential in the treatment of bladder cancer. Inflammation-based biomarkers have recently emerged as potential tools for improving cancer diagnostics and prognostication. This study aims to evaluate the potential value of the Systemic Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), Pan-immune Inflammation Value (PIV), and Platelet-to-Lymphocyte Ratio (PLR) as predictors of muscle-invasive disease. Materials and methods: Analyzed data included 310 bladder tumors. The SII, SIRI, PIV, and PLR were calculated from pre-TURBT complete blood-count results. Differences in inflammatory markers between pathological stages (pTa–pT4) were examined using ANOVA with Tukey’s post hoc testing. Optimal cutoff values for distinguishing NMIBC from MIBC were identified using ROC curve analysis and Youden’s J statistic. Logistic regression models incorporating age, sex, the number of recurrences, and each inflammatory index were developed to evaluate their predictive performance in patients treated with curative intent. Results: All investigated inflammation indices significantly differed across tumor stages (p < 0.001), with lower values observed in pTa tumors compared with muscle-invasive disease. Determined cutoff values for muscle-invasive disease were 865.63 for SII, 2.02 for SIRI, 579.28 for PIV, and 166.35 for PLR. Logistic regression models demonstrated promising diagnostic performance, achieving AUC values of 0.812 (SII), 0.816 (SIRI), 0.821 (PIV), and 0.795 (PLR); sensitivity and specificity were 76% and 75% for SII, 79% and 77% for SIRI, 80% and 72% for PIV, and 88% and 59% for PLR. Discussion: The presented results indicate that inflammation-based indices vary meaningfully between bladder cancer stages and may be utilized in early identification of muscle-invasive disease. As inexpensive and widely available biomarkers, they offer potential value in the evaluation of suspected MIBC before the final pathology report and could enhance the diagnostic process.
Open AccessInflammation Indices as Predictive Markers of Muscle-Invasive Bladder Cancer
Introduction: Prompt diagnosis and differentiation between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) are essential in the treatment of bladder cancer. Inflammation-based biomarkers have recently emerged as potential tools for improving cancer diagnostics and prognostication. This study aims to evaluate the potential value of the Systemic Inflammation Index (SII), Systemic Inflammation Response Index (SIRI), Pan-immune Inflammation Value (PIV), and Platelet-to-Lymphocyte Ratio (PLR) as predictors of muscle-invasive disease. Materials and methods: Analyzed data included 310 bladder tumors. The SII, SIRI, PIV, and PLR were calculated from pre-TURBT complete blood-count results. Differences in inflammatory markers between pathological stages (pTa–pT4) were examined using ANOVA with Tukey’s post hoc testing. Optimal cutoff values for distinguishing NMIBC from MIBC were identified using ROC curve analysis and Youden’s J statistic. Logistic regression models incorporating age, sex, the number of recurrences, and each inflammatory index were developed to evaluate their predictive performance in patients treated with curative intent. Results: All investigated inflammation indices significantly differed across tumor stages (p < 0.001), with lower values observed in pTa tumors compared with muscle-invasive disease. Determined cutoff values for muscle-invasive disease were 865.63 for SII, 2.02 for SIRI, 579.28 for PIV, and 166.35 for PLR. Logistic regression models demonstrated promising diagnostic performance, achieving AUC values of 0.812 (SII), 0.816 (SIRI), 0.821 (PIV), and 0.795 (PLR); sensitivity and specificity were 76% and 75% for SII, 79% and 77% for SIRI, 80% and 72% for PIV, and 88% and 59% for PLR. Discussion: The presented results indicate that inflammation-based indices vary meaningfully between bladder cancer stages and may be utilized in early identification of muscle-invasive disease. As inexpensive and widely available biomarkers, they offer potential value in the evaluation of suspected MIBC before the final pathology report and could enhance the diagnostic process.
- Open Access
Dust Mite-Specific IgE in Nasal Lavage Fluid During Natural Allergen Exposure and After Nasal Provocation Test in Subjects with Suspected Local Allergic Rhinitis
Introduction: Apart from the typical AR phenotype and its standard clinical manifestations—rhinorrhea, sneezing, nasal itching, and congestion—the so-called local allergic rhinitis (LAR) can be observed in a subset of subjects presenting rhinitis symptoms, a negative skin prick test (SPT), and serum-specific immunoglobulin E (sIgE) for the relevant allergens and confirmed with a positive nasal provocation test (NPT), which is the gold standard in LAR diagnosis. Our study aims to assess the clinical symptoms and local mucosal sIgE presence induced by NPT and natural exposure to HDM allergens in subjects with suspected LAR. Methods: In total, 25 suspected LAR subjects were included in the study. The total nasal symptom score (TNSS) and visual analog scale (VAS) were used for the subjective assessment. A nasal provocation test (NPT) was performed with house dust mite allergens. The nasal lavage technique was used for nasal secretion acquisition, in which the levels of sIgE were measured. Results: During the period of increased exposure vs. the off-exposure period, the TNSS and VAS were significantly higher (p = 0.0361 and p = 0.0031, respectively). Levels of IgE specific to Dermatophagoides pteronyssinus in nasal lavage were high (p = 0.0502). Similarly, high levels of sIgE to Dermatophagoides farinae were noted (p = 0.0164). Comparing pre-NPT and post-NPT results, LAR diagnosis was confirmed in 8 subjects. Only the VAS score was higher after a positive NPT. Both sIgE to Dermatophagoides pteronyssinus and Dermatophagoides farinae in nasal lavage were higher after a positive NPT; however, the change was not statistically significant. A higher fold change in the median relative value (sIgE/Total IgE) for both allergens was noted in the positive-NPT group compared to the negative-NPT group. Conclusions: Assessing the local nasal production of sIgE and other inflammatory mediators may contribute to expanding our knowledge of LAR pathogenesis. Further studies including a larger number of subjects are needed for a better understanding of the LAR entity in terms of diagnosis and treatment options.
Open AccessDust Mite-Specific IgE in Nasal Lavage Fluid During Natural Allergen Exposure and After Nasal Provocation Test in Subjects with Suspected Local Allergic Rhinitis
Introduction: Apart from the typical AR phenotype and its standard clinical manifestations—rhinorrhea, sneezing, nasal itching, and congestion—the so-called local allergic rhinitis (LAR) can be observed in a subset of subjects presenting rhinitis symptoms, a negative skin prick test (SPT), and serum-specific immunoglobulin E (sIgE) for the relevant allergens and confirmed with a positive nasal provocation test (NPT), which is the gold standard in LAR diagnosis. Our study aims to assess the clinical symptoms and local mucosal sIgE presence induced by NPT and natural exposure to HDM allergens in subjects with suspected LAR. Methods: In total, 25 suspected LAR subjects were included in the study. The total nasal symptom score (TNSS) and visual analog scale (VAS) were used for the subjective assessment. A nasal provocation test (NPT) was performed with house dust mite allergens. The nasal lavage technique was used for nasal secretion acquisition, in which the levels of sIgE were measured. Results: During the period of increased exposure vs. the off-exposure period, the TNSS and VAS were significantly higher (p = 0.0361 and p = 0.0031, respectively). Levels of IgE specific to Dermatophagoides pteronyssinus in nasal lavage were high (p = 0.0502). Similarly, high levels of sIgE to Dermatophagoides farinae were noted (p = 0.0164). Comparing pre-NPT and post-NPT results, LAR diagnosis was confirmed in 8 subjects. Only the VAS score was higher after a positive NPT. Both sIgE to Dermatophagoides pteronyssinus and Dermatophagoides farinae in nasal lavage were higher after a positive NPT; however, the change was not statistically significant. A higher fold change in the median relative value (sIgE/Total IgE) for both allergens was noted in the positive-NPT group compared to the negative-NPT group. Conclusions: Assessing the local nasal production of sIgE and other inflammatory mediators may contribute to expanding our knowledge of LAR pathogenesis. Further studies including a larger number of subjects are needed for a better understanding of the LAR entity in terms of diagnosis and treatment options.